Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15

Keybanc analyst Steve Dechert has maintained an Overweight rating on LifeStance Health Group (NASDAQ: LFST) and raised the price target from $13 to $15. This adjustment reflects a positive outlook on the company's performance.